131 related articles for article (PubMed ID: 4851277)
1. Defective monocyte chemotactic response in genitourinary carcinoma.
Brosman S; Hausman MS
Urology; 1974 Aug; 4(2):129-34. PubMed ID: 4851277
[No Abstract] [Full Text] [Related]
2. Defective monocyte function in patients with genitourinary carcinoma.
Hausman MS; Brosman S; Snyderman R; Mickey MR; Fahey J
J Natl Cancer Inst; 1975 Nov; 55(5):1047-54. PubMed ID: 1107568
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a 3-H-proline microcytotoxicity test.
Bean MA; Pees H; FOGH JE; Grabstald H; Oettgen HF
Int J Cancer; 1974 Aug; 14(2):186-97. PubMed ID: 4477555
[No Abstract] [Full Text] [Related]
4. Correlation among host immunocompetence and tumor stage, tumor grade and vascular permeation in transitional carcinoma.
Catalona WJ; Chretien PB
J Urol; 1973 Nov; 110(5):526-8. PubMed ID: 4750895
[No Abstract] [Full Text] [Related]
5. Cellular immunity in bladder cancer patients.
Guinan P; McKiel C; Flanagan M; Bhatti R; Pessis D; Ablin RJ
J Urol; 1978 Jun; 119(6):747-9. PubMed ID: 660759
[TBL] [Abstract][Full Text] [Related]
6. Serum induced lymphoid cell mediated cytotoxicity to human transitional cell carcinomas of the genitourinary tract.
Hakala TR; Lange PH
Science; 1974 May; 184(4138):795-7. PubMed ID: 4856602
[TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen in patients with urologic cancers.
Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
[No Abstract] [Full Text] [Related]
8. Effect of radiation therapy for urologic cancer on circulating thymus-derived lymphocytes.
Catalona WJ; Potvin C; Chretien PB
J Urol; 1974 Aug; 112(2):261-7. PubMed ID: 4546361
[No Abstract] [Full Text] [Related]
9. Blood group H antigen in transitional carcinoma of the urinary bladder.
Tichý M; Tichá V; Jansa P; Student V; Vanák J
Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
[TBL] [Abstract][Full Text] [Related]
10. Correlation between tumour stage, tumour grade, and immunocompetence in patients with carcinoma of the bladder and prostate.
Adolphs HD; Steffens L
Eur Urol; 1977; 3(1):23-5. PubMed ID: 837950
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen (CEA) in plasma of patients with carcinoma of the bladder/urethra.
Orjasaeter H; Fosså SD; Schjølseth SA; Fjaestad K
Cancer; 1978 Jul; 42(1):287-95. PubMed ID: 667800
[No Abstract] [Full Text] [Related]
12. [Case of combined clear-cell and transitional-cell carcinoma of one kidney with transitional-cell carcinoma of the bladder].
Petrov P; Tachev S; Dar U
Khirurgiia (Sofiia); 1986; 39(5):97-9. PubMed ID: 3784404
[No Abstract] [Full Text] [Related]
13. Cell mediated cytotoxicity against human transitional cell carcinomas of the genitourinary tract.
Hakala TR; Lange PH; Castro A; Elliott A; Fraley EE
Cancer; 1974 Dec; 34(6):1929-34. PubMed ID: 4434325
[No Abstract] [Full Text] [Related]
14. Lymphocyte-mediated cytotoxicity in patients with renal and transitional cell carcinoma receiving BCG.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):343-5. PubMed ID: 748791
[TBL] [Abstract][Full Text] [Related]
15. Triple synchronous genitourinary malignancies of dissimilar histogenesis.
Wentworth SA; Head RW; Stewart R
Urology; 1985 Mar; 25(3):313. PubMed ID: 3976123
[No Abstract] [Full Text] [Related]
16. Immunologic features of genitourinary cancer.
Javadpour N
Urology; 1973 Aug; 2(2):103-8. PubMed ID: 4129366
[No Abstract] [Full Text] [Related]
17. Abnormalities of cell-mediated immunocompetence in genitourinary cancer.
Catalona WJ; Chretien PB; Trahan EE
J Urol; 1974 Feb; 111(2):229-32. PubMed ID: 4855735
[No Abstract] [Full Text] [Related]
18. [Hypernephroma 8 years after transitional carcinoma of the bladder].
Arango Toro OJ; Perscky Arravanti IM; Tores Falco C; Gelabert i Mas A
Arch Esp Urol; 1985; 38(1):63-4. PubMed ID: 3994427
[No Abstract] [Full Text] [Related]
19. Correlation of urine cytology with ABO(H) antigenicity in transitional cell carcinoma of the bladder.
Das G; Glashan RW
J Clin Pathol; 1988 May; 41(5):538-9. PubMed ID: 3384984
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen and bladder carcinoma.
Ionescu G; Romas NA; Ionascu L; Bennett S; Tannenbaum M; Veeneman RJ; Lattimer JK
J Urol; 1976 Jan; 115(1):46-8. PubMed ID: 1107601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
